AnaptysBio Q2 net income more than doubles to $177.3 million on 23.5% revenue rise
AnaptysBio posted Q2 net income from continuing operations of USD 177.3 million, versus USD 5.7 million a year earlier. Q2 collaboration revenue rose 23.47% year over year to USD 27.49 million. Cash, cash equivalents and investments totaled USD 164.1 million at June 30, down from USD 211.6 million at Dec. 31, 2025. Man